In Vivo TLR9 Inhibition Attenuates CpG-Induced Myocardial Dysfunction

Figure 1

(a)–(c) In vitro evaluation of different doses of TLR9 inhibitors. RAW 264.7 macrophages were stimulated with feces of C57BL/6 WT mice simultaneously with different TLR9 inhibitors for 24 h and TNF-α protein content was monitored via ELISA (mean ± SEM; 𝑛=5; *𝑃<0.05; *also indicates the significant group).

(a)

(b)

(c)